Reprogramming Myoblasts to Stem Cells Using a Small Molecule
Author Information
Author(s): Pasha Zeeshan Haider, Husnain Kh Ashraf, Muhammad Anversa
Primary Institution: Department of Pathology, University of Cincinnati
Hypothesis
Can skeletal myoblasts be reprogrammed to induced pluripotent stem cells using a non-viral method?
Conclusion
The study successfully demonstrated that skeletal myoblasts can be reprogrammed to induced pluripotent stem cells using a DNMT inhibitor without genetic manipulation.
Supporting Evidence
- SiPS cells showed morphological and molecular characteristics similar to embryonic stem cells.
- Transplantation of SiPS-derived cardiac progenitor cells improved heart function in a mouse model of myocardial infarction.
- SiPS cells formed teratomas in immunodeficient mice, indicating pluripotency.
Takeaway
Scientists found a way to turn muscle cells into stem cells using a special chemical, which could help heal damaged hearts without causing tumors.
Methodology
Skeletal myoblasts from transgenic mice were treated with a DNMT inhibitor, RG108, to induce pluripotency and then assessed for stem cell characteristics and cardiac differentiation.
Potential Biases
Potential bias in the interpretation of results due to the use of a single small molecule for reprogramming.
Limitations
The study primarily focused on a specific mouse model and may not directly translate to human applications.
Participant Demographics
Young male Oct3/4-GFP+ transgenic mice were used for the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website